COVID-19 Breakthrough Infections and Transmission Risk: Real-World Data Analyses from Germany’s Largest Public Health Department (Cologne)
Background and Methods: Vaccination is currently considered the most successful strategy for combating the SARS-CoV-2 virus. According to short-term clinical trials, protection against infection is estimated to reach up to 95% after complete vaccination (≥14 days after receipt of all recommended COV...
Main Authors: | Lea Hsu, Barbara Grüne, Michael Buess, Christine Joisten, Jan Klobucnik, Johannes Nießen, David Patten, Anna Wolff, Gerhard A. Wiesmüller, Annelene Kossow, Julia Hurraß |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/11/1267 |
Similar Items
-
Unpacking the Implications of SARS-CoV-2 Breakthrough Infections on COVID-19 Vaccination Programs
by: Tafadzwa Dzinamarira, et al.
Published: (2022-02-01) -
Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination in a high-risk national population
by: Adeel A. Butt, et al.
Published: (2021-10-01) -
Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination
by: Sharon Walmsley, et al.
Published: (2023-12-01) -
Long COVID: The latest manifestations, mechanisms, and potential therapeutic interventions
by: Shi‐ting He, et al.
Published: (2022-12-01) -
Risk Stratification of SARS-CoV-2 Breakthrough Infections Based on an Outbreak at a Student Festive Event
by: Ralph Bertram, et al.
Published: (2022-03-01)